Annual FCF
-$18.76 M
+$17.41 M+48.13%
June 30, 2024
Summary
- As of February 8, 2025, IBIO annual free cash flow is -$18.76 million, with the most recent change of +$17.41 million (+48.13%) on June 30, 2024.
- During the last 3 years, IBIO annual FCF has risen by +$16.46 million (+46.73%).
- IBIO annual FCF is now -1205.50% below its all-time high of -$1.44 million, reached on June 30, 2008.
Performance
IBIO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$3.71 M
+$1.14 M+23.47%
September 30, 2024
Summary
- As of February 8, 2025, IBIO quarterly free cash flow is -$3.71 million, with the most recent change of +$1.14 million (+23.47%) on September 30, 2024.
- Over the past year, IBIO quarterly FCF has increased by +$1.14 million (+23.47%).
- IBIO quarterly FCF is now -652.99% below its all-time high of $671.80 thousand, reached on June 30, 2009.
Performance
IBIO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$16.93 M
+$1.63 M+8.76%
September 30, 2024
Summary
- As of February 8, 2025, IBIO TTM free cash flow is -$16.93 million, with the most recent change of +$1.63 million (+8.76%) on September 30, 2024.
- Over the past year, IBIO TTM FCF has increased by +$1.63 million (+8.76%).
- IBIO TTM FCF is now -3547.71% below its all-time high of -$464.10 thousand, reached on December 31, 2009.
Performance
IBIO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
IBIO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.1% | +23.5% | +8.8% |
| 3 y3 years | +46.7% | -1.2% | +62.9% |
| 5 y5 years | -25.4% | -1.2% | +62.9% |
IBIO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +61.8% | -1.7% | +77.4% | at high | +67.6% |
| 5 y | 5-year | -29.4% | +61.8% | -2.8% | +77.4% | -17.8% | +67.6% |
| alltime | all time | -1205.5% | +61.8% | -653.0% | +77.4% | -3547.7% | +67.6% |
IBio Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.71 M(-23.5%) | -$16.93 M(-8.8%) |
| Jun 2024 | -$18.76 M(-48.1%) | -$4.85 M(+32.8%) | -$18.55 M(-3.2%) |
| Mar 2024 | - | -$3.65 M(-22.4%) | -$19.18 M(-0.1%) |
| Dec 2023 | - | -$4.71 M(-11.9%) | -$19.19 M(-23.5%) |
| Sep 2023 | - | -$5.34 M(-2.5%) | -$25.08 M(-30.7%) |
| Jun 2023 | -$36.17 M(-26.3%) | -$5.48 M(+49.2%) | -$36.17 M(-20.7%) |
| Mar 2023 | - | -$3.67 M(-65.3%) | -$45.63 M(-8.7%) |
| Dec 2022 | - | -$10.59 M(-35.6%) | -$49.98 M(-4.3%) |
| Sep 2022 | - | -$16.44 M(+10.1%) | -$52.21 M(+6.3%) |
| Jun 2022 | -$49.11 M(+39.4%) | -$14.93 M(+86.2%) | -$49.11 M(+11.7%) |
| Mar 2022 | - | -$8.02 M(-37.4%) | -$43.96 M(-0.8%) |
| Dec 2021 | - | -$12.82 M(-3.9%) | -$44.30 M(+8.3%) |
| Sep 2021 | - | -$13.34 M(+36.4%) | -$40.91 M(+16.1%) |
| Jun 2021 | -$35.23 M(+143.0%) | -$9.78 M(+16.9%) | -$35.23 M(+16.9%) |
| Mar 2021 | - | -$8.37 M(-11.2%) | -$30.13 M(+17.5%) |
| Dec 2020 | - | -$9.43 M(+23.2%) | -$25.65 M(+29.3%) |
| Sep 2020 | - | -$7.65 M(+63.3%) | -$19.84 M(+36.8%) |
| Jun 2020 | -$14.50 M(-3.1%) | -$4.69 M(+20.7%) | -$14.50 M(+0.8%) |
| Mar 2020 | - | -$3.88 M(+7.4%) | -$14.38 M(-2.7%) |
| Dec 2019 | - | -$3.61 M(+55.9%) | -$14.77 M(-8.9%) |
| Sep 2019 | - | -$2.32 M(-49.2%) | -$16.21 M(+8.4%) |
| Jun 2019 | -$14.96 M(+2.8%) | -$4.57 M(+6.8%) | -$14.96 M(+6.5%) |
| Mar 2019 | - | -$4.27 M(-15.5%) | -$14.06 M(+2.1%) |
| Dec 2018 | - | -$5.06 M(+374.1%) | -$13.77 M(+10.2%) |
| Sep 2018 | - | -$1.07 M(-70.8%) | -$12.50 M(-14.2%) |
| Jun 2018 | -$14.56 M(-1.3%) | -$3.66 M(-8.2%) | -$14.56 M(-4.2%) |
| Mar 2018 | - | -$3.98 M(+5.2%) | -$15.19 M(+0.8%) |
| Dec 2017 | - | -$3.79 M(+21.1%) | -$15.07 M(+0.4%) |
| Sep 2017 | - | -$3.13 M(-27.1%) | -$15.01 M(+1.7%) |
| Jun 2017 | -$14.76 M(+81.3%) | -$4.29 M(+11.0%) | -$14.76 M(+10.5%) |
| Mar 2017 | - | -$3.86 M(+3.7%) | -$13.35 M(+12.0%) |
| Dec 2016 | - | -$3.73 M(+29.6%) | -$11.92 M(+21.0%) |
| Sep 2016 | - | -$2.88 M(-0.2%) | -$9.85 M(+21.0%) |
| Jun 2016 | -$8.14 M | -$2.88 M(+18.2%) | -$8.14 M(+24.7%) |
| Mar 2016 | - | -$2.44 M(+47.5%) | -$6.53 M(+19.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | - | -$1.65 M(+42.0%) | -$5.47 M(-0.7%) |
| Sep 2015 | - | -$1.17 M(-8.3%) | -$5.50 M(+11.4%) |
| Jun 2015 | -$4.94 M(+12.9%) | -$1.27 M(-7.8%) | -$4.94 M(+11.9%) |
| Mar 2015 | - | -$1.38 M(-18.6%) | -$4.41 M(+0.7%) |
| Dec 2014 | - | -$1.69 M(+181.5%) | -$4.38 M(+9.4%) |
| Sep 2014 | - | -$601.00 K(-19.1%) | -$4.01 M(-8.4%) |
| Jun 2014 | -$4.38 M(-13.3%) | -$743.00 K(-44.8%) | -$4.38 M(-4.4%) |
| Mar 2014 | - | -$1.34 M(+2.1%) | -$4.58 M(+1.1%) |
| Dec 2013 | - | -$1.32 M(+35.8%) | -$4.53 M(-3.0%) |
| Sep 2013 | - | -$970.00 K(+2.5%) | -$4.67 M(-7.5%) |
| Jun 2013 | -$5.04 M(-19.4%) | -$946.00 K(-26.8%) | -$5.04 M(-3.0%) |
| Mar 2013 | - | -$1.29 M(-11.3%) | -$5.20 M(-24.9%) |
| Dec 2012 | - | -$1.46 M(+8.1%) | -$6.93 M(+10.2%) |
| Sep 2012 | - | -$1.35 M(+22.6%) | -$6.28 M(+0.4%) |
| Jun 2012 | -$6.25 M(+15.1%) | -$1.10 M(-63.6%) | -$6.25 M(+1.7%) |
| Mar 2012 | - | -$3.02 M(+271.1%) | -$6.15 M(+18.5%) |
| Dec 2011 | - | -$813.90 K(-38.4%) | -$5.19 M(-15.7%) |
| Sep 2011 | - | -$1.32 M(+33.0%) | -$6.16 M(+13.3%) |
| Jun 2011 | -$5.43 M(+85.7%) | -$992.80 K(-51.9%) | -$5.43 M(+8.1%) |
| Mar 2011 | - | -$2.06 M(+15.8%) | -$5.02 M(+12.5%) |
| Dec 2010 | - | -$1.78 M(+198.7%) | -$4.47 M(+46.3%) |
| Sep 2010 | - | -$596.10 K(+1.9%) | -$3.05 M(+4.3%) |
| Jun 2010 | -$2.93 M(+12.9%) | -$585.00 K(-61.1%) | -$2.93 M(+75.3%) |
| Mar 2010 | - | -$1.50 M(+310.6%) | -$1.67 M(+259.5%) |
| Dec 2009 | - | -$366.40 K(-21.9%) | -$464.10 K(-66.8%) |
| Sep 2009 | - | -$469.30 K(-169.9%) | -$1.40 M(-46.0%) |
| Jun 2009 | -$2.59 M(+80.3%) | $671.80 K(-323.8%) | -$2.59 M(-26.9%) |
| Mar 2009 | - | -$300.20 K(-76.9%) | -$3.55 M(-4.8%) |
| Dec 2008 | - | -$1.30 M(-21.7%) | -$3.73 M(+41.6%) |
| Sep 2008 | - | -$1.66 M(+488.1%) | -$2.63 M(+83.1%) |
| Jun 2008 | -$1.44 M(-13.4%) | -$282.60 K(-41.1%) | -$1.44 M(+24.5%) |
| Mar 2008 | - | -$480.10 K(+132.6%) | -$1.15 M(+71.2%) |
| Dec 2007 | - | -$206.40 K(-55.9%) | -$674.50 K(+44.1%) |
| Sep 2007 | - | -$468.10 K | -$468.10 K |
| Jun 2007 | -$1.66 M | - | - |
FAQ
- What is iBio annual free cash flow?
- What is the all time high annual FCF for iBio?
- What is iBio annual FCF year-on-year change?
- What is iBio quarterly free cash flow?
- What is the all time high quarterly FCF for iBio?
- What is iBio quarterly FCF year-on-year change?
- What is iBio TTM free cash flow?
- What is the all time high TTM FCF for iBio?
- What is iBio TTM FCF year-on-year change?
What is iBio annual free cash flow?
The current annual FCF of IBIO is -$18.76 M
What is the all time high annual FCF for iBio?
iBio all-time high annual free cash flow is -$1.44 M
What is iBio annual FCF year-on-year change?
Over the past year, IBIO annual free cash flow has changed by +$17.41 M (+48.13%)
What is iBio quarterly free cash flow?
The current quarterly FCF of IBIO is -$3.71 M
What is the all time high quarterly FCF for iBio?
iBio all-time high quarterly free cash flow is $671.80 K
What is iBio quarterly FCF year-on-year change?
Over the past year, IBIO quarterly free cash flow has changed by +$1.14 M (+23.47%)
What is iBio TTM free cash flow?
The current TTM FCF of IBIO is -$16.93 M
What is the all time high TTM FCF for iBio?
iBio all-time high TTM free cash flow is -$464.10 K
What is iBio TTM FCF year-on-year change?
Over the past year, IBIO TTM free cash flow has changed by +$1.63 M (+8.76%)